U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07525986) titled 'Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery' on April 06.
Brief Summary: Visceral pain following laparoscopic surgery is frequently underestimated, yet it is associated with a range of adverse outcomes. Effective visceral pain management should constitute an essential component of postoperative analgesic strategies following laparoscopic procedures. However, conventional analgesic agents, including μ-opioid receptor agonists, lack specificity for visceral pain. Anrikefon, a novel selective peripheral κ-opioid receptor agonist, demonstrates unique efficacy in alleviating visceral...